Abstract:Aim: Our cohort study aimed to investigate the dynamic changes of lymphocyte subsets and their abilities to predict disease severity and prognosis in primary infection and unvaccinated COVID-19 patients. Methods: A total of 773 cases, including 718 primary infection and unvaccinated COVID-19 patients and 55 controls. COVID-19 patients were assigned to severe and nonsevere groups according to disease severity, as well as survival and death groups according to prognosis. Serum samples were collected to measure the numbers of total lymphocytes and lymphocyte subsets. The differences among different severity groups were analyzed. Spearman correlation was performed to assess associations between lymphocyte subsets and disease severity and prognosis. Meanwhile, receiver operating characteristic (ROC) curves were also analyzed to find optimal cutoff points. Results: At admission, the severe group demonstrated significantly lower total lymphocyte counts and percentages, CD3+ and CD3+CD4+ T cell counts and percentages, CD3+CD8+ T cell counts, CD19+ B cell counts and CD56+ NK cell counts and percentages than the nonsevere group. Meanwhile, compared with the survival group, the death group also had lower total lymphocyte counts and percentages, CD3+, CD3+CD4+ and CD3+CD8+ T cell counts. Additionally, differences in these parameters were also noticed within four weeks after admission. Furthermore, Spearman analysis reported that disease severity was negatively correlated with lymphocyte counts and percentages, CD3+, CD3+CD4+ and CD3+CD8+ T cell counts, CD3+ and CD3+CD4+ T cell percentages (r=-0.166, -0.179, -0.173, -0.186, -0.127, -0.117, -0.149, respectively)(all P<0.05). The prognosis of death was also negatively correlated with total lymphocyte counts and percentages, CD3+, CD3+CD4+ and CD3+CD8+ T cell counts (r=-0.125, -0.121, -0.123, -0.123, -0.091, respectively)(all P<0.05). Conclusion: In primary infection and unvaccinated COVID-19 patients total lymphocytes and T cell, B cell and NK cell subsets at COVID-19 onset play valuable roles in predicting disease severity and prognosis. Clinical trial registry: Chinese Clinical Trial Register ChiCTR2000034563.

Dynamic Response Landscape of Immune Cells Identified Immune Dysfunction Which Predicts Disease Progression in COVID-19 Infected Patients.

Analysis of the Dynamic Relationship Between Immune Profiles and the Clinical Features of Patients with COVID-19

Dynamic blood single-cell immune responses in patients with COVID-19

Dynamic changes in peripheral blood lymphocyte subsets in adult patients with COVID-19

Single-cell landscape of immunological responses in patients with COVID-19

Dynamic Behavior of Lymphocyte Subgroups Correlates with Clinical Outcomes in Human H7N9 Infection.

Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19

A Landscape Study on COVID-19 Immunity at the Single-Cell Level

The Transient IFN Response and the Delay of Adaptive Immunity Feature the Severity of COVID-19

Biomarkers and Immune Repertoire Metrics Identified by Peripheral Blood Transcriptomic Sequencing Reveal the Pathogenesis of COVID-19

Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19

Identification of Distinct Immune Cells Associated with Various Clinical Presentations of COVID-19

Single-cell transcriptomes of peripheral blood cells indicate and elucidate severity of COVID-19

Continuous tracking of COVID-19 patients' immune status

Elevated Exhaustion Levels of NK and CD8+ T Cells as Indicators for Progression and Prognosis of COVID-19 Disease

Dynamic Characteristics of Lymphocyte Subsets and Their Predictive Value for Disease Progression and Prognosis in Primary Infection and Unvaccinated COVID-19 Patients

Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing

The differential immune responses to COVID-19 in peripheral and lung revealed by single-cell RNA sequencing

Longitudinal peripheral blood transcriptional analysis of COVID-19 patients captures disease progression and reveals potential biomarkers

Differential expression of lymphocyte subpopulations in the peripheral blood of patients with COVID‚Äź19: Implications for disease severity and prognosis

Single-cell landscape of immunological responses in COVID-19 patients